icon-folder.gif   Conference Reports for NATAP  
 
  ID Week
Oct 8-12 2014
Philadelphia
Back grey_arrow_rt.gif
 
 
 
Simplification to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF from Ritonavir-Boosted Protease Inhibitor Plus Emtricitabine/Tenofovir DF Maintains HIV Suppression and Improves Fasting Triglycerides at Week 48
 
 
  Reported by Jules Levin
October 6-8, 2014
Infectious Disease Week
October 8-12, 2014
Philadelphia, PA
 
D Cunningham1, D Shamblaw2, C Zurawski3, W Robbins4, A Scarsella5, T Nguyen6, J Hindman6, R Ebrahimi6, D Piontkowsky6
1Pueblo Family Physicians, Phoenix, AZ, USA; 2La Playa Medical Group and Clinical Research, San Diego, CA, USA; 3Atlanta ID Group, Atlanta, GA, USA; 4Value Health MD, Orlando, FL, USA; 5Pacific Oaks Medical Group, Los Angeles, CA, USA; 6Gilead Sciences, Foster City, CA, USA

IDSA1.gif

IDSA2.gif

IDSA3.gif

IDSA4.gif

IDSA5.gif

IDSA6.gif

IDSA7.gif

IDSA8.gif

IDSA9.gif

IDSA10.gif